These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8652722)

  • 1. The potential role of azithromycin in the treatment of prophylaxis of toxoplasmosis.
    Chang HR
    Int J STD AIDS; 1996; 7 Suppl 1():18-22. PubMed ID: 8652722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to oral and intravenous azithromycin in a patient with toxoplasma encephalitis and AIDS.
    Wiselka MJ; Read R; Finch RG
    J Infect; 1996 Nov; 33(3):227-9. PubMed ID: 8945715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
    Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
    Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS.
    Jacobson JM; Hafner R; Remington J; Farthing C; Holden-Wiltse J; Bosler EM; Harris C; Jayaweera DT; Roque C; Luft BJ;
    AIDS; 2001 Mar; 15(5):583-9. PubMed ID: 11316995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.
    Lopes CD; Silva NM; Ferro EA; Sousa RA; Firminot ML; Bernardes ES; Roque-Barreira MC; Pena JD
    J Parasitol; 2009 Aug; 95(4):1005-10. PubMed ID: 20050006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Azithromycin combined with pyrimethamine in the treatment of neurotoxoplasmosis, in an AIDS patient].
    Trotta M; Sterrantino G; Milo D; Dionisio D; Leoncini F
    Minerva Med; 1997 Mar; 88(3):117-9. PubMed ID: 9148227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxoplasmosis in AIDS].
    Leport C; Remington JS
    Presse Med; 1992 Jul 4-11; 21(25):1165-71. PubMed ID: 1409466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic approaches for AIDS-related toxoplasmosis.
    Behbahani R; Moshfeghi M; Baxter JD
    Ann Pharmacother; 1995; 29(7-8):760-8. PubMed ID: 8520094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary toxoplasmosis.
    Campagna AC
    Semin Respir Infect; 1997 Jun; 12(2):98-105. PubMed ID: 9195674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
    Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
    Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of azithromycin in a murine toxoplasmosis model, employing a Toxoplasma gondii strain from Turkey.
    Değerli K; Kilimcioğlu AA; Kurt O; Tamay AT; Ozbilgin A
    Acta Trop; 2003 Sep; 88(1):45-50. PubMed ID: 12943976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and prophylaxis of Mycobacterium avium complex.
    Young LS
    Int J STD AIDS; 1996; 7 Suppl 1():23-7. PubMed ID: 8652724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of toxoplasmosis in immunocompromised patients].
    Morlat P; Leport C
    Ann Med Interne (Paris); 1997; 148(3):235-9. PubMed ID: 9255332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The evaluation of the efficacy of azithromycin and pyrimethamine used alone or in combination in the treatment of an experimental infection in mice by Toxoplasma gondii].
    Braz LM; Di Pietro AO; Amato Neto V; França FO
    Rev Soc Bras Med Trop; 1999; 32(4):401-3. PubMed ID: 10495670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin in the prophylaxis of opportunistic infections in AIDS.
    McCutchan JA
    Int J STD AIDS; 1996; 7 Suppl 1():34-7. PubMed ID: 8652726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendation for diagnostics and therapy of toxoplasmosis in persons with HIV infection].
    Machala L; Kodym P; Rozsypal H; Stanková M; Sedlácek D
    Klin Mikrobiol Infekc Lek; 2007 Dec; 13(6):248-52. PubMed ID: 18320505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients.
    Laing RB; Flegg PJ; Brettle RP; Leen CL; Burns SM
    Int J STD AIDS; 1996 Jul; 7(4):258-64. PubMed ID: 8876356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin prophylaxis and treatment of murine toxoplasmosis.
    Tabbara KF; Hammouda E; Tawfik A; Al-Omar OM; Abu El-Asrar AM
    Saudi Med J; 2005 Mar; 26(3):393-7. PubMed ID: 15806206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.